| J9299 | Injection, nivolumab, 1 mg | 20,680 | $20 | $496.3K |
| J9271 | Injection, pembrolizumab, 1 mg | 7,800 | $40 | $335.4K |
| J0897 | Injection, denosumab, 1 mg | 2,520 | $20 | $45.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $100 | $32.6K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 300 | $80 | $24K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $100 | $23.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 200 | $70 | $13.6K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 60 | $120 | $7.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $120 | $4.6K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 170 | $20 | $4K |